Mutations in CHMP2 have been implicated in the neurodegenerative diseases, Frontotemporal Dementia (FTD) [25] and Amyotrophic Lateral Sclerosis (ALS) [26]. Here, CHMP2A is linked to amyotrophic lateral sclerosis.